Clinical features of heteroresistant vancomycin-intermediate Staphylococcus aureus bacteremia versus those of methicillin-resistant S. aureus bacteremia

Pharmacology, Toxicology and Pharmaceutical Science

• Bloodstream Infection 100%
• Meticillin 100%
• Staphylococcus Aureus 100%
• Staphylococcal Bacteremia 100%
• Clinical Feature 100%
• Vancomycin Intermediate Staphylococcus Aureus 100%
• Infection 30%
• Rifampicin 20%
• Comorbidity 20%
• Prevalence 10%
• Staphylococcal Infection 10%
• Endocarditis 10%
• Osteomyelitis 10%
• Immobility 10%

Keyphrases

• Clinical Features 100%
• Staphylococcus Aureus Bacteremia 100%
• Methicillin-resistant S. Aureus 100%
• Vancomycin-intermediate Staphylococcus Aureus 100%
• S. Aureus Bacteremia 100%
• Bacteremia 20%
• Rifampicin Resistance 20%
• Infection-related Mortality 20%
• No Significant Difference 10%
• Comorbidity 10%
• Medical Records 10%
• Logistic Regression 10%
• Female Sex 10%
• Length of Hospital Stay 10%
• Endocarditis 10%
• Charlson Comorbidity Index 10%
• Staphylococcal Infections 10%
• Osteomyelitis 10%
• Clinical Significance 10%
• Hospital-acquired Infection 10%
• Bedridden 10%
• Attributable Mortality 10%

Immunology and Microbiology

• Staphylococcus Aureus 100%
• Vancomycin Intermediate Staphylococcus Aureus 100%
• Comorbidity 20%
• Medical Record 10%
• Prevalence 10%
• Endocarditis 10%